When SVI supporter Alison Hyams was introduced to Dr Kate Firipis, she was inspired to support Kate’s career by funding a Rising Star Fellowship.
SVI was honoured to welcome back esteemed alumnus Professor Zihe Rao for a special seminar last week. Professor Rao returned to the institute where he earned his PhD four decades ago, now as a world-renowned scientist.
SVI’s Discovery Fund stands as a testament to the power of philanthropy in driving groundbreaking medical research. Since its inception, the aim of the Fund has been to help bridge gaps in funding and accelerate life-saving discoveries.
The SVI Vascular Biology team have received a generous research grant from the LEO Foundation, Denmark, an organisation dedicated to curing skin diseases across the globe.
Dr. Haniyeh Hemmatian is the latest recipient of SVI's Rising Star Fellowship. The generous donation will help bolster research into understanding the underlying causes of bone-loss related diseases.
Professor André La Gerche, Head of the Heart Exercise And Research Trials (HEART) Lab, recently appeared on the lab’s podcast to discuss the little-known impacts of sudden cardiac death (SCD).
Former SVI laboratory assistant and pioneer of protein sequencing, Geoff Begg, recently returned to the Institute to visit the fruits of his labour, which take pride of place in SVI’s foyer.
After eight years of service as SVI Board Chair, Tony Reeves is handing the torch to fellow Board member, Michael Burn.
PhD student Ben Turner in the Protein Chemistry and Metabolism Lab has received a generous Top-Up Scholarship from the Elaine Walters Foundation.
SVI scientists have recently made an important discovery about how cells grow and handle stress, which could lead to new ways to treat cancer.
SVI scientists have discovered a major superfamily of bacterial proteins that create enormous holes in cell membranes. This discovery marks an exciting step toward harnessing nature’s own molecular arsenal for future biomedical advancements.
SVI scientists have developed a simple blood test – requiring just a small amount of blood – that can measure disease-causing immune responses associated with type 1 diabetes, potentially transforming the way the disease is detected and managed in children.
Thanks to our generous donors, SVI is laying the groundwork for new advances in diabetes, cancer and other diseases. On Wednesday 26 March, we came together to celebrate their contributions toward SVI's purchase of an IncuCyte Live Cell Imaging Platform, a cutting-edge tool that will significantly enhance our research efforts.
Two accomplished leaders, with skills in business, media, governance, and community service, have joined SVI’s Foundation Board. Kathryn Fink is the Director of Television at SBS, and Maree Davenport is a strategic advisor, author, and former Victorian MP.
The new Microbiome lab, a collaboration between SVI, St Vincent’s Hospital Melbourne, and the University of Melbourne, with support from The Australasian Gastro Intestinal Research Foundation (AGIRF), has wasted no time in commencing their groundbreaking research.
Dr Emma van der Westhuizen has received a grant from the National Foundation for Medical Research and Innovation (NFMRI) and the Mason Foundation (managed by Equity Trustees) to reach new frontiers in Alzheimer’s disease research.
On Valentine’s Day eve, SVI’s annual For the Love of Science dinner transported 250 passionate and generous supporters of medical research to the romantic streets of Paris at Fitzroy Town Hall.
SVI's Dr Seigmund Lai has been awarded the prestigious Breakthrough T1D – formerly JDRF – Postdoctoral Fellowship, valued at $400,000 over three years.
People affected by type 1 diabetes, cancer and lung disease are set to benefit from more than $6.5 million of funding awarded to three SVI scientists in the latest round of Investigator Grant funding from the National Health and Medical Research Council (NHMRC).
Dr Melissa John has been awarded $50,000 from the Department of Health and Aged Care through the Australian Centre for HIV and Hepatitis Virology Research (ACH4) to support the development of a blood collection device with potential use in the diagnosis of infection with human T lymphotropic virus type 1 (HTLV-1).